Reliability and Validity of the Spanish Version of the Substance Dependence Severity Scale

Vélez-Moreno, Antonio; González‐Sáiz, Francisco; Rojas, Antonio J.; Linares, Esperanza Torrico; Fernández‐Calderón, Fermín; Ramírez-López, Juan; Lozano, Óscar

doi:10.1159/000365282

Cited by 15 publications

(10 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The composite scores of each dimension ranged from 0 to 1, while higher scores indicated greater severity. The reliability measures indicated moderate to good internal consistency in the European samples (Cronbach's alpha: 0.69-0.92) [50,51].…”

Section: Plos Onementioning

confidence: 91%

Impulsive and premeditated aggression in male offenders with antisocial personality disorder

et al. 2020

View full text Add to dashboard Cite

aggression. ASPD patients with impulsive aggression had significantly lower scores of total PCL-R (p<0.01) factor 1 and interpersonal facet 1 (p<0.05), compared with ASPD patients with premeditated aggression. ASPD patients with impulsive aggression and ASPD patients with premeditated aggression had comparable BIS-11 mean scores, and exhibited an equal prevalence of SUDs. The interpersonal facet 1of the PCL-R predicted the aggression type (p<0.05) in ASPD patients, and the exponential beta value for facet 1 was 1.42 (CI = 1.03; 1.95). Conclusions The aggression type that is associated with ASPD is mainly impulsive in nature. ASPD patients who have higher scores of psychopathic traits have a lower probability of exhibiting impulsive aggression and a higher probability of exhibiting premeditated aggression. Although ASPD patients have high levels of impulsivity and a high frequency of SUDs, these two variables were not predictors of the aggression type.

show abstract

Section: Plos Onementioning

confidence: 91%

Impulsive and premeditated aggression in male offenders with antisocial personality disorder

et al. 2020

View full text Add to dashboard Cite

show abstract

“…The Spanish version of the Substance Dependence Severity Scale (SDSS; Miele et al, 2000) was used (Vélez-Moreno et al, 2013; Vélez-Moreno et al, 2015). This measure assesses the severity of DSM-IV substance dependence during the 30 days prior to the interview.…”

Section: Methodsmentioning

confidence: 99%

Adult ADHD Self-Report Scale: Comprehensive Psychometric Study in a Spanish SUD Sample

et al. 2016

Self Cite

View full text Add to dashboard Cite

show abstract

“…Its test-retest reliability for alcohol is excellent: ICC 0.90 [0.79-0.88] for severity and ICC 0.82 [0.77-0.86]. The reliability and concurrent validity of the Spanish version have also been studied and behave very similarly to the original scale [35]. The RAs will be trained on the procedures to apply this instrument according to what has been reported by the authors.…”

Section: Secondary Outcomesmentioning

confidence: 99%

Brief motivational therapy versus enhanced usual care for alcohol use disorders in primary care in Chile: study protocol for an exploratory randomized trial

Barticevic

Poblete

Zuzulich

et al. 2020

Trials

View full text Add to dashboard Cite

Background: Harmful alcohol use is a leading cause of global disability and death. However, increased detection and brief intervention capacity of more severe alcohol use disorders has not been accompanied by increased availability of treatment services. Incorporating treatment for such disorders into primary care is of paramount importance for improving access and health outcomes. This study aims to estimate the effectiveness of a Brief Motivational Treatment (BMT) applied in primary care for treatment of these disorders. Methods: A parallel-group, single-blinded, severity-stratified, randomized clinical trial will test the superiority of BMT over enhanced usual care. Eligible participants will be those seeking treatment and who fulfill DSM-V criteria for alcohol use disorder and criteria for harmful alcohol use. With an estimated a loss to follow-up of 20%, a total of 182 participants will be recruited and equally randomized to each treatment group. The intervention group will receive an adaptation of the motivational enhancement therapy, as manualized in Project MATCH. This treatment consists of four 45-min sessions provided by a general psychologist with at least 3 years of primary care experience. The primary outcome is the change from baseline in the drinks per drinking day during the last 90 days, which will be captured using the Timeline Follow Back method. Secondary outcomes will describe the changes in alcohol use pattern, motivational status, and severity of the disorder. All participants will be analyzed according to the group they were allocated, regardless of the treatment actually received. Mean differences (MD) will be computed for continuous outcomes and relative risks (RR) and RR reductions (RRR) for dichotomous results. Linear models will deliver the subgroup analyses. Missingness is assumed to be associated with the baseline alcohol use pattern and severity, so a multiple imputation method will be used to handle missing data. Discussion: This trial aims to test the superiority of BMT over enhanced usual care with a reasonable superiority margin, over which the BMT could be further considered for incorporation into PC in Chile. Its pragmatic approach ultimately aims to inform policymakers about the benefit of including a brief psychosocial treatment into PC. Trial registration: ClinicalTrials.gov NCT04345302. Registered on

show abstract

Reliability and Validity of the Spanish Version of the Substance Dependence Severity Scale

Cited by 15 publications

References 26 publications

Impulsive and premeditated aggression in male offenders with antisocial personality disorder

Impulsive and premeditated aggression in male offenders with antisocial personality disorder

Adult ADHD Self-Report Scale: Comprehensive Psychometric Study in a Spanish SUD Sample

Brief motivational therapy versus enhanced usual care for alcohol use disorders in primary care in Chile: study protocol for an exploratory randomized trial

Contact Info

Product

Resources

About